3 days Ago By ABMN Staff
Exicure, Inc. ( NASDAQ:XCUR – Get Free Report ) saw a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 129,500 shares, a decline of 31.
1% from the August 15th total of 187,900 shares. Based on an average daily trading volume, of 533,000 shares, the short-interest ratio is currently 0.2 days.
Approximately 14.4% of the shares of the company are short sold. Exicure Stock Up 4.
6 % Shares of XCUR stock opened at $1.60 on Monday. The stock has a 50 day moving average of $0.
49 and a 200-day moving average of $0.24. The firm has a market cap of $13.
84 million, a PE ratio of -1.05 and a beta of 1.24.
Exicure has a 12 month low of $1.44 and a 12 month high of $4.75.
Exicure ( NASDAQ:XCUR – Get Free Report ) last released its earnings results on Tuesday, August 13th. The company reported ($0.01) EPS for the quarter.
About Exicure Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.
Further Reading Receive News & Ratings for Exicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exicure and related companies with MarketBeat.com's FREE daily email newsletter ..
